Scarica l'app Stockscreener
92.14
0.87%
-0.81
Pre-mercato:
92.52
0.38
+0.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$92.95
Aprire:
$93.57
Volume 24 ore:
143.81K
Relative Volume:
1.00
Capitalizzazione di mercato:
$2.07B
Reddito:
$213.03M
Utile/perdita netta:
$41.32M
Rapporto P/E:
76.15
EPS:
1.21
Flusso di cassa netto:
$33.49M
1 W Prestazione:
-0.53%
1M Prestazione:
-13.88%
6M Prestazione:
+11.98%
1 anno Prestazione:
+62.33%
Intervallo 1D:
$92.01
$93.93
Intervallo di 1 settimana:
$91.28
$94.34
Portata 52W:
$52.88
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Confronta LMAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
92.14 | 2.07B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Ripresa | Lake Street | Buy |
| 2024-05-31 | Ripresa | ROTH MKM | Buy |
| 2024-04-26 | Aggiornamento | Stifel | Hold → Buy |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-06 | Iniziato | Oppenheimer | Outperform |
| 2023-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Iniziato | Jefferies | Buy |
| 2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
| 2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
| 2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Reiterato | Barrington Research | Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Ripresa | ROTH Capital | Buy |
| 2018-04-26 | Downgrade | Stifel | Buy → Hold |
| 2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Iniziato | First Analysis Sec | Overweight |
| 2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
| 2016-07-28 | Reiterato | Barrington Research | Outperform |
| 2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
Sanctuary Advisors LLC Makes New $181,000 Investment in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Increased by Franklin Resources Inc. - Defense World
Jane Street Group LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Jane Street Group LLC - MarketBeat
(LMAT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
Barclays PLC Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Barclays PLC - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Geode Capital Management LLC Acquires 23,443 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Average PT from Brokerages - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Has More To Do To Multiply In Value Going Forward - Simply Wall St
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by HighTower Advisors LLC - Defense World
LeMaitre Vascular prices $150M convertible senior notes - MSN
LeMaitre Vascular Prices $150 Million Convertible Senior Notes - Defense World
LeMaitre Vascular's SWOT analysis: niche market leader faces valuation scrutiny - Investing.com
December 2025 Options Now Available For LeMaitre Vascular (LMAT) - Nasdaq
State Street Corp Buys 28,525 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular Announces $150 Million Convertible Senior Notes OfferingUnited States-based medical device company LeMaitre Vascular, Inc. (NASDAQ: LMAT) revealed its plans for a substantial financial move on December 16, 2024. The company disc - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Fmr LLC Buys 8,114 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular Prices $150M Convertible Notes Offering - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Holdings Boosted by Fmr LLC - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap DownShould You Sell? - MarketBeat
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering - The Manila Times
LeMaitre Vascular to Offer $150M in Convertible Notes - TipRanks
M&T Bank Corp Buys New Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Crude Oil Brent (SCK24) Quote - The Globe and Mail
Ultra Bloomberg Natural Gas 2X ETF (BOIL-A) QuotePress Release - The Globe and Mail
Stifel Financial Corp Has $6.71 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India
StockNews.com Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Hold - MarketBeat
Janus Henderson Group PLC Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
United Rentals (URI-N) QuotePress Release - The Globe and Mail
TSX Composite High Beta Index (TXHB) QuotePress Release - The Globe and Mail
Transdigm Group Inc (TDG-N) QuotePress Release - The Globe and Mail
Cardiac Valvulotome Market Top Companies StudyLeMaitre, - openPR
LeMaitre Vascular (NASDAQ:LMAT) sheds 5.5% this week, as yearly returns fall more in line with earnings growth - Simply Wall St
Charles Schwab Investment Management Inc. Has $17.79 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Charles Schwab Investment Management Inc. Has $17.79 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
BNP Paribas Financial Markets Purchases 12,432 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Upgraded by StockNews.com - Defense World
(LMAT) Trading Advice - Stock Traders Daily
Bridgewater Associates LP Sells 15,389 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Target Price at $94.57 - Defense World
Townsquare Capital LLC Acquires 13,210 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Strategic Sale: James John OConnor Decides To Exercise Options Worth $527K At LeMaitre Vascular - Benzinga
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $94.57 - MarketBeat
Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular - Benzinga
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):